TY - JOUR
T1 - C-type lectin Mincle mediates cell death-triggered inflammation in acute kidney injury
AU - Tanaka, Miyako
AU - Saka-Tanaka, Marie
AU - Ochi, Kozue
AU - Fujieda, Kumiko
AU - Sugiura, Yuki
AU - Miyamoto, Tomofumi
AU - Kohda, Hiro
AU - Ito, Ayaka
AU - Miyazawa, Taiki
AU - Matsumoto, Akira
AU - Aoe, Seiichiro
AU - Miyamoto, Yoshihiro
AU - Tsuboi, Naotake
AU - Maruyama, Shoichi
AU - Suematsu, Makoto
AU - Yamasaki, Sho
AU - Ogawa, Yoshihiro
AU - Suganami, Takayoshi
N1 - Funding Information:
The authors thank Dr. Makoto Arita (Keio University) for technical advice for lipidomics analysis, Dr. Michio Nakaya for phagocytosis analysis, and Drs. Shizuo Akira and Masaru Okabe for their generous gifts of Mincle KO mice and Egfp Tg mice. We also thank the members of the Suganami laboratory for helpful discussion and the Center for Animal Research and Education (CARE), Nagoya University, for support with animal experiments. This work was supported in part by Grants-in-Aid for Scientific Research fromthe Ministry of Education, Culture, Sports, Science and Technology of Japan (17H05500, 20H03447, 20H05503, and 20H04944 to T. Suganami and 18K08508 to M. Tanaka) and the Japan Agency for Medical Research and Development (Core Research for Evolutional Science and Technology; JP19gm1210009s0101 to T. Suganami and JP19gm0610011h9905 to Y. Ogawa). The imaging metabolomics platform was established by the Japan Science and Technology Agency Exploratory Research for Advanced Technology Suematsu Gas Biology Project led by M. Suematsu until March 2015. This study was also supported by research grants from The Hori Sciences and Arts Foundation, the Takeda Science Foundation, The NOVARTIS Foundation (Japan) for the Promotion of Science (to T. Suganami), the Terumo Life Science Foundation, The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, the ONO Medical Research Foundation, the Ishibashi Yukiko Foundation, and the Daiichi Sankyo Foundation of Life Science (to M. Tanaka) and the Aichi Kidney Foundation (to M. Saka-Tanaka).
Funding Information:
Disclosures: N. Tsuboi reported grants from Chugai Pharmaceutical Co., Ltd., personal fees from Chugai Pharmaceutical Co., Ltd., personal fees from Kyowa Kirin Co., Ltd., personal fees from Mochida Pharmaceutical Co., Ltd., personal fees from Sa-nofi K.K., personal fees from Eisai Co., Ltd., grants from The Ministry of Education, Culture, Sports, Science and Technology, Japan, grants from Grant-in-Aid from Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Renal Disease, grants from Japan Agency for Medical Research and Development, grants from Asahi Kasei Medical Co., Ltd., and grants from Novartis Pharma K.K. outside the submitted work. No other disclosures were reported.
Funding Information:
This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (17H05500, 20H03447, 20H05503, and 20H04944 to T. Suganami and 18K08508 to M. Tanaka) and the Japan Agency for Medical Research and
Funding Information:
Development (Core Research for Evolutional Science and Technology; JP19gm1210009s0101 to T. Suganami and JP19gm0610011h9905 to Y. Ogawa). The imaging metabolomics platform was established by the Japan Science and Technology Agency Exploratory Research for Advanced Technology Suematsu Gas Biology Project led by M. Suematsu until March 2015. This study was also supported by research grants from The Hori Sciences and Arts Foundation, the Takeda Science Foundation, The NOVARTIS Foundation (Japan) for the Promotion of Science (to T. Suganami), the Terumo Life Science Foundation, The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, the ONO Medical Research Foundation, the Ishibashi Yukiko Foundation, and the Daiichi Sankyo Foundation of Life Science (to M. Tanaka) and the Aichi Kidney Foundation (to M. Saka-Tanaka).
Publisher Copyright:
© 2020 Rockefeller University Press. All rights reserved.
PY - 2020/8
Y1 - 2020/8
N2 - Accumulating evidence indicates that cell death triggers sterile inflammation and that impaired clearance of dead cells causes nonresolving inflammation; however, the underlying mechanisms are still unclear. Here, we show that macrophage-inducible C-type lectin (Mincle) senses renal tubular cell death to induce sustained inflammation after acute kidney injury in mice. Mincle-deficient mice were protected against tissue damage and subsequent atrophy of the kidney after ischemia-reperfusion injury. Using lipophilic extract from the injured kidney, we identified β-glucosylceramide as an endogenous Mincle ligand. Notably, free cholesterol markedly enhanced the agonistic effect of β-glucosylceramide on Mincle. Moreover, β-glucosylceramide and free cholesterol accumulated in dead renal tubules in proximity to Mincle-expressing macrophages, where Mincle was supposed to inhibit clearance of dead cells and increase proinflammatory cytokine production. This study demonstrates that β-glucosylceramide in combination with free cholesterol acts on Mincle as an endogenous ligand to induce cell death-triggered, sustained inflammation after acute kidney injury.
AB - Accumulating evidence indicates that cell death triggers sterile inflammation and that impaired clearance of dead cells causes nonresolving inflammation; however, the underlying mechanisms are still unclear. Here, we show that macrophage-inducible C-type lectin (Mincle) senses renal tubular cell death to induce sustained inflammation after acute kidney injury in mice. Mincle-deficient mice were protected against tissue damage and subsequent atrophy of the kidney after ischemia-reperfusion injury. Using lipophilic extract from the injured kidney, we identified β-glucosylceramide as an endogenous Mincle ligand. Notably, free cholesterol markedly enhanced the agonistic effect of β-glucosylceramide on Mincle. Moreover, β-glucosylceramide and free cholesterol accumulated in dead renal tubules in proximity to Mincle-expressing macrophages, where Mincle was supposed to inhibit clearance of dead cells and increase proinflammatory cytokine production. This study demonstrates that β-glucosylceramide in combination with free cholesterol acts on Mincle as an endogenous ligand to induce cell death-triggered, sustained inflammation after acute kidney injury.
UR - http://www.scopus.com/inward/record.url?scp=85089482164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089482164&partnerID=8YFLogxK
U2 - 10.1084/JEM.20192230
DO - 10.1084/JEM.20192230
M3 - Article
C2 - 32797195
AN - SCOPUS:85089482164
SN - 0022-1007
VL - 217
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 11
M1 - e20192230
ER -